The book series aims to publish articles that can serve as important tools for both industry and researchers working in this interdisciplinary field. The carefully selected collection of publications aims to provide continuous inspiration for new research and development and highlight technologies that can generate great humanitarian and commercial value.

The main editor of the book is Professor Peter Lieberzeit at the University of Viennaand the team at Attana has written the chapter together with Dr Nicholas Jones, Withers & Rogers (IP) and Professor Ian Nicholls and Dr Subramanian Suriyanarayanan at Linnaeus University.

The chapter "Robust QCM-Based Sensing and Assay Formats in Commercialized Systems" describes how Attana's analytical instrument functions and is applied.

Attana's unique and patented technology for kinetic interaction studies makes it possible to perform various analyzes in real time on human cells and tissue as well as in blood. With a focus on optimizing, selecting, and validating drug candidates before clinical trials, Attana has helped pharmaceutical companies to streamline their drug process and these companies are significantly more in clinical studies than the industry average.

For Attana, the book is important as it provides strong recognition for Attana's world-leading technology in the biosensor market. The chapter will be able to be used as an introduction for many potential customers, as it provides a good summary of opportunities to perform more body-like studies and how these studies are carried out in practical terms.